Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Acta Derm Venereol ; 97(6): 675-684, 2017 Jun 09.
Artículo en Inglés | MEDLINE | ID: mdl-27882385

RESUMEN

Keloid disease is a fibroproliferative tumour characterised by aggressive local invasion, evident from a clinically and histologically active migrating margin. During combined laser capture microdissection and microarray analysis-based in situ gene expression profiling, we identified upregulation of the polypeptide growth factor neuregulin-1 (NRG1) and ErbB2 oncogene in keloid margin dermis, leading to the hypothesis that NRG1 contributed to keloid margin migration through ErbB2-mediated signalling. The aim of this study was to probe this hypothesis through functional in vitro studies. Exogenous NRG1 addition to keloid and normal skin fibroblasts altered cytokine expression profiles, significantly increased in vitro migration and keloid fibroblast Src and protein tyrosine kinase 2 (PTK2/FAK) gene expression. ErbB2 siRNA knockdown attenuated both keloid fibroblast migration and Src/PTK2 expression, which were not recovered following NRG1 administration, suggesting the NRG1/ErbB2/Src/PTK2 signaling pathway may be a novel regulator of keloid fibroblast migration, and representing a potential new therapeutic target.


Asunto(s)
Movimiento Celular , Fibroblastos/enzimología , Queloide/enzimología , Neurregulina-1/metabolismo , Receptor ErbB-2/metabolismo , Piel/enzimología , Estudios de Casos y Controles , Células Cultivadas , Citocinas/genética , Citocinas/metabolismo , Fibroblastos/patología , Quinasa 1 de Adhesión Focal/genética , Quinasa 1 de Adhesión Focal/metabolismo , Humanos , Queloide/genética , Queloide/patología , Neurregulina-1/genética , Interferencia de ARN , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptor ErbB-2/genética , Transducción de Señal , Piel/patología , Factores de Tiempo , Transfección , Regulación hacia Arriba , Familia-src Quinasas/genética , Familia-src Quinasas/metabolismo
2.
J Hand Microsurg ; 16(1): 100006, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38854370

RESUMEN

Objective: We encountered the case of a patient who presented with an avulsion of both flexor digitorum profundus (FDP) and flexor digitorum superficialis (FDS) tendons from their respective insertion in the ring finger. We aim to discuss the novel treatment of this injury pattern in the context of all previously encountered cases in the literature. Materials and Methods: We examined the case of our patient with avulsion of both flexor tendons in the same finger and discuss the novel method of treatment in our case. Additionally, we performed a literature review of all previous reported cases and discuss the treatment modalities and outcomes associated with each. Results: We have shown a novel and successful treatment technique for avulsion of both the FDP and FDS tendons. We identified twelve other cases of this injury pattern and have compared all outcomes documented. Conclusion: Closed tendon avulsion of both flexor tendons in the same finger is rare. We described a case and additionally propose a modification to the flexor tendon avulsion classification to incorporate this injury pattern and aid its management.

3.
Arch Plast Surg ; : 594-598, 2019 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-31018632

RESUMEN

Overall complication rates of 9.1% have been reported following implantable cardioverter defibrillator (ICD) placement. Brachial plexus injury is infrequently reported in the literature. We describe a 26-year-old female experiencing left arm nerve pain, a positive Tinel's sign, numbness in the median nerve distribution of the hand and biceps muscle weakness following revision ICD via subclavian vein approach. Nerve conduction studies identified severe partial left brachial plexopathy, which remained incompletely resolved with conservative management. Surgical exploration revealed lateral cord impingement by the ICD generator and a loop of the ICD lead, along with fibrosis, necessitating surgical neurolysis and ICD generator repositioning. As increasing numbers of patients undergo cardiac device implantation, it is incumbent on practitioners to be aware of potential increases in the prevalence of this complication.

4.
J Invest Dermatol ; 136(7): 1500-1512, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27025872

RESUMEN

Keloid disease is a recurrent fibroproliferative cutaneous tumor of unknown pathogenesis for which clinical management remains unsatisfactory. To obtain new insights into hitherto underappreciated aspects of keloid pathobiology, we took a laser capture microdissection-based, whole-genome microarray analysis approach to identify distinct keloid disease-associated gene expression patterns within defined keloid regions. Identification of the aldo-keto reductase enzyme AKR1B10 as highly up-regulated in keloid epidermis suggested that an imbalance of retinoic acid metabolism is likely associated with keloid disease. Here, we show that AKR1B10 transfection into normal human keratinocytes reproduced the abnormal retinoic acid pathway expression pattern we had identified in keloid epidermis. Cotransfection of AKR1B10 with a luciferase reporter plasmid showed reduced retinoic acid response element activity, supporting the hypothesis of retinoic acid synthesis deficiency in keloid epidermis. Paracrine signals released by AKR1B10-overexpressing keratinocytes into conditioned medium resulted in up-regulation of transforming growth factor-ß1, transforming growth factor-ß2, and collagens I and III in both keloid and normal skin fibroblasts, mimicking the typical profibrotic keloid profile. Our study results suggest that insufficient retinoic acid synthesis by keloid epidermal keratinocytes may contribute to the pathogenesis of keloid disease. We refocus attention on the role of injured epithelium in keloid disease and identify AKR1B10 as a potential new target in future management of keloid disease.


Asunto(s)
Aldehído Reductasa/metabolismo , Epidermis/metabolismo , Queloide/metabolismo , Tretinoina/metabolismo , Aldo-Ceto Reductasas , Medios de Cultivo Condicionados , Epidermis/patología , Fibroblastos/metabolismo , Fibrosis , Regulación de la Expresión Génica , Humanos , Queloide/patología , Queratinocitos/citología , Análisis de Secuencia por Matrices de Oligonucleótidos , Plásmidos/metabolismo , Elementos de Respuesta , Transducción de Señal , Activación Transcripcional , Regulación hacia Arriba
5.
BMJ ; 356: j961, 2017 02 23.
Artículo en Inglés | MEDLINE | ID: mdl-28232315
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA